Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight or Obesity

NCT07791654

Study summary

ClinicalTrials.gov

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight or Obesity

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention MWN109 1 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention MWN109 2 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention MWN109 3 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2025-08-23

PhasePHASE2

Conditions

Overweight , Obesityunresolved

Interventions

MWN109 1DRUG

MWN109 2DRUG

MWN109 3DRUG

PlaceboDRUG

Sponsors & collaborators

Shanghai Minwei Biotechnology Co., Ltdlead sponsor

Mapped research locations

LuoyangHenan, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07791654 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.